Lingfang Biology
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Lingfang Biology - overview
Established
2020
Location
Shenzhen, Guangdong, China
Primary Industry
Pharmaceuticals
About
Established in 2020 and based in Shenzhen, China, Lingfang Biology is a pharmaceutical company that provides anti-tumor targeted drugs. The company's R&D team has decades of experience in new drug development. The company focuses on the research and development of anti-tumor targeted drugs for gastric cancer, liver cancer, pancreatic cancer, and etc. The company has six product lines and some of its products are in pre-clinical development stage.
Lingfang Biology will put the funding towards to advance the clinical development of the product and expand the product pipeline.
Current Investors
Cowin Capital, Shanghai Zhizhong Private Equity Fund Management
Primary Industry
Pharmaceuticals
Sub Industries
Specialty Pharmaceuticals, Pharmaceutical Research & Development
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.